Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET)

NCT01607476 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

89

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: C11 PiB
DRUG: F18 Flutametamol

Sponsor

Mayo Clinic